Latest News Releases2 December

ETRI, DGIST develop new electrode structure for all-solid-state secondary battery

National Research Council of Science & Technology
Research News Release

South Korean researchers have developed a new type of electrode structure for all-solid-state secondary batteries. If this technology is adopted, the energy density of the batteries could increase significantly when compared to existing technologies, contributing tremendously to the development of high-performance secondary batteries.

Journal: ACS Energy Letters
Funder: Ministry of Science and ICT

Building resiliency in children as the COVID-19 pandemic continues through the holidays

Nationwide Children's Hospital
Research News Release

A new survey by Nationwide Children's Hospital found two-thirds of parents worry the effects of the pandemic on their children's mental health will be more challenging to recover from the longer it continues. With adjustments to a child's home environment, empathetic family conversations and thoughtful planning, parents can set kids up for success.

Keeping California a powerhouse of almond production

American Society of Agronomy
Research News Release

Research shows nitrogen efficiency and productivity not a tradeoff.

Meeting: 2020 ASA-CSSA-SSSA Annual Meeting
Funder: United States Department of Agriculture California Specialty Crop Block Grants, the Foundation for Food and Agricultural Research, the California Department of Food and Agriculture Fertilizer Research and Education Program, Almond Board of California

Building resiliency in children as the COVID-19 pandemic continues through the holidays

Nationwide Children's Hospital
Research News Release

Octapharma presents results of study on Octagam® 10% for severe COVID-19 patients at ASH

Yankee Public Relations
Research News Release

Clinical research presented by Octapharma USA at the 62nd American Society of Hematology (ASH) Annual Meeting and Exposition will highlight the investigational use of high-dose Octagam® 10% [Immune Globulin Intravenous (Human)] for the most severe COVID-19 patients. Octapharma's intravenous immunoglobulin (IVIg) portfolio also will be featured in a study design poster focused on primary infection prophylaxis in patients with chronic lymphocytic leukemia during ASH, to be held virtually December 5 - 8 due to the coronavirus pandemic.

Meeting: 2020 American Society of Hematology
Funder: Octapharma

1 December

More evidence that cellular 'death by iron' could be promising avenue of cancer treatment

Memorial Sloan Kettering Cancer Center

Glucosamine may reduce overall death rates as effectively as regular exercise

West Virginia University

COVID-19 may deepen depression, anxiety, and PTSD among pregnant and postpartum women

Brigham and Women's Hospital

1 December

Featured Newsrooms

Latest News Releases2 December

1 December

More evidence that cellular 'death by iron' could be promising avenue of cancer treatment

Glucosamine may reduce overall death rates as effectively as regular exercise

COVID-19 may deepen depression, anxiety, and PTSD among pregnant and postpartum women